Total N=286791 Men N=153987 Women N=132804 <55 years N=37221 55-74 years N=153250 ≥75 years N=96320 <=2 years duration N=46923 3-5 years duration N=74383 6-10 years duration N=61052 >10 years duration
N=32509
eGFR ≥60 N=157305 eGFR 30-59 N=32597 eGFR <30 N=2266
Lifestyle Only 24.4 24.6 24.1 29.8 23.2 24.1 37.8 25.5 18.5 12.7 22.0 19.0 19.0
Metformin 41.2 41.7 40.5 44.7 44.3 34.9 43.8 41.8 40.6 36.6 45.8 36.4 16.2
Sulphonylurea 17.4 17.7 17.2 11.4 16.6 21.2 10.0 17.6 21.1 21.2 17.9 19.9 12.1
Glitazone 0.8 0.8 0.9 0.8 0.9 0.8 0.3 0.8 1.1 1.2 0.7 1.1 1.2
Glinide 2.4 2.4 2.4 1.7 2.3 2.9 1.5 2.5 2.8 2.8 2.1 3.6 8.0
Insulin 12.4 11.5 13.5 10.7 11.5 14.5 5.6 10.4 14.3 23.9 10.0 18.3 42.6
Othera 1.4 1.3 1.4 1.0 1.3 1.6 1.0 1.4 1.5 1.5 1.3 1.6 0.9
aOther: Alphaglucosidase inhibitor, DPP4 inhibitor or GLP-1 analog (exenatide)
eGFR: Estimated Glomerular Filtration Rate
Table 3: Use of glycaemic-lowering drugs by age, sex, diabetes duration and renal function.